Literature DB >> 22565208

Alzheimer disease: biomarker trajectories across stages of Alzheimer disease.

Giovanni B Frisoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22565208     DOI： 10.1038/nrneurol.2012.81

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  8 in total

1.  Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Clifford R Jack; Marilyn S Albert; David S Knopman; Guy M McKhann; Reisa A Sperling; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Shapes of the trajectories of 5 major biomarkers of Alzheimer disease.

Authors:  Clifford R Jack; Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; Timothy G Lesnick; Val Lowe; Kejal Kantarci; Matt A Bernstein; Matthew L Senjem; Jeffrey L Gunter; Bradley F Boeve; John Q Trojanowski; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; David S Knopman
Journal:  Arch Neurol       Date:  2012-07

3.  Alzheimer's Disease Neuroimaging Initiative special issue.

Authors:  Giovanni B Frisoni; Michael W Weiner
Journal:  Neurobiol Aging       Date:  2010-06-08       Impact factor: 4.673

Review 4.  Alzheimer's disease: clinical trials and drug development.

Authors:  Francesca Mangialasche; Alina Solomon; Bengt Winblad; Patrizia Mecocci; Miia Kivipelto
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

Review 5.  The clinical use of structural MRI in Alzheimer disease.

Authors:  Giovanni B Frisoni; Nick C Fox; Clifford R Jack; Philip Scheltens; Paul M Thompson
Journal:  Nat Rev Neurol       Date:  2010-02       Impact factor: 42.937

6.  Mapping the effects of Abeta1-42 levels on the longitudinal changes in healthy aging: hierarchical modeling based on stationary velocity fields.

Authors:  Marco Lorenzi; Nicholas Ayache; Giovanni B Frisoni; Xavier Pennec
Journal:  Med Image Comput Comput Assist Interv       Date:  2011

7.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

Review 8.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

Authors:  Bruno Dubois; Howard H Feldman; Claudia Jacova; Steven T Dekosky; Pascale Barberger-Gateau; Jeffrey Cummings; André Delacourte; Douglas Galasko; Serge Gauthier; Gregory Jicha; Kenichi Meguro; John O'brien; Florence Pasquier; Philippe Robert; Martin Rossor; Steven Salloway; Yaakov Stern; Pieter J Visser; Philip Scheltens
Journal:  Lancet Neurol       Date:  2007-08       Impact factor: 44.182
  8 in total
  14 in total

1.  Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth.

Authors:  Kelly R Murphy; Susan M Landau; Kingshuk Roy Choudhury; Christopher A Hostage; Katie S Shpanskaya; Haris I Sair; Jeffrey R Petrella; Terence Z Wong; P Murali Doraiswamy
Journal:  Neuroimage       Date:  2013-04-23       Impact factor: 6.556

2.  Atrophy and lower regional perfusion of temporo-parietal brain areas are correlated with impairment in memory performances and increase of EEG upper alpha power in prodromal Alzheimer's disease.

Authors:  Vito Davide Moretti
Journal:  Am J Neurodegener Dis       Date:  2015-09-10

3.  Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease.

Authors:  Robert X Smith; Jeremy F Strain; Aaron Tanenbaum; Anne M Fagan; Jason Hassenstab; Eric McDade; Suzanne E Schindler; Brian A Gordon; Chengjie Xiong; Jasmeer Chhatwal; Clifford Jack; Celeste Karch; Sarah Berman; Jared R Brosch; James J Lah; Adam M Brickman; David M Cash; Nick C Fox; Neill R Graff-Radford; Johannes Levin; James Noble; David M Holtzman; Colin L Masters; Martin R Farlow; Christoph Laske; Peter R Schofield; Daniel S Marcus; John C Morris; Tammie L S Benzinger; Randall J Bateman; Beau M Ances
Journal:  Brain Connect       Date:  2021-03-31

4.  Theta and alpha EEG frequency interplay in subjects with mild cognitive impairment: evidence from EEG, MRI, and SPECT brain modifications.

Authors:  Davide V Moretti
Journal:  Front Aging Neurosci       Date:  2015-03-20       Impact factor: 5.750

Review 5.  Mild Cognitive Impairment: Structural, Metabolical, and Neurophysiological Evidence of a Novel EEG Biomarker.

Authors:  Davide Vito Moretti
Journal:  Front Neurol       Date:  2015-07-06       Impact factor: 4.003

6.  EEG upper/low alpha frequency power ratio relates to temporo-parietal brain atrophy and memory performances in mild cognitive impairment.

Authors:  Davide V Moretti; Donata Paternicò; Giuliano Binetti; Orazio Zanetti; Giovanni B Frisoni
Journal:  Front Aging Neurosci       Date:  2013-10-25       Impact factor: 5.750

Review 7.  A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis.

Authors:  Daniela Perani; Perani Daniela; Orazio Schillaci; Schillaci Orazio; Alessandro Padovani; Padovani Alessandro; Flavio Mariano Nobili; Nobili Flavio Mariano; Leonardo Iaccarino; Iaccarino Leonardo; Pasquale Anthony Della Rosa; Della Rosa Pasquale Anthony; Giovanni Frisoni; Frisoni Giovanni; Carlo Caltagirone; Caltagirone Carlo
Journal:  Biomed Res Int       Date:  2014-03-19       Impact factor: 3.411

8.  Increase of theta frequency is associated with reduction in regional cerebral blood flow only in subjects with mild cognitive impairment with higher upper alpha/low alpha EEG frequency power ratio.

Authors:  Davide V Moretti; Annapaola Prestia; Giuliano Binetti; Orazio Zanetti; Giovanni B Frisoni
Journal:  Front Behav Neurosci       Date:  2013-12-05       Impact factor: 3.558

9.  Association of EEG, MRI, and regional blood flow biomarkers is predictive of prodromal Alzheimer's disease.

Authors:  Davide Vito Moretti
Journal:  Neuropsychiatr Dis Treat       Date:  2015-10-27       Impact factor: 2.570

10.  Electroencephalography-driven approach to prodromal Alzheimer's disease diagnosis: from biomarker integration to network-level comprehension.

Authors:  Davide Vito Moretti
Journal:  Clin Interv Aging       Date:  2016-07-06       Impact factor: 4.458
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.